The causes of emesis associated with anaesthesia are varied and in any one patient are likely to be multifactorial. Our approach has been to emphasise those areas which can be controlled. However, general prophylactic measures, such as reduced gastric inflation, avoidance of opiate premedication and pharyngeal stimulation, might not be sufficient to prevent emesis. Although we do not recommend routine preoperative use of antiemetics because of their relatively high incidence of side effects, we do feel there is a place for prophylaxis under certain circumstances. Our drug of choice for prophylaxis would be droperidol 0.175 mg·kg
-1 intravenously, given peroperatively, although a smaller dose can be effective. For operations involving the ear we would prefer promethazine given with the premedication or peroperatively. Once nausea and vomiting have begun, cyclizine 25–50 mg intramuscularly, or one of the piperazine phenothiazines (prochlor-perazine or perphenazine), would be appropriate. In the event of the first choice drug being ineffective, we would encourage the use of a second agent, preferably one with a different site of action. We feel that familiarity with a few drugs and more attention to the controllable factors mentioned should help reduce postoperative emesis.
An erratum to this article is available at
. http://dx.doi.org/10.1007/BF03008552 Reference
Palazzo MGA, Strunin L.
Anaesthesia and emesis. Part I: Etiology. Can Anaesth Soc J 1984; 31:178–877.
Horton RE, Ross FGM, Darling GH.
Determination of the emptying time of the stomach by use of enteric coated barium granules. Br Med J 1965; 1:1537–9.
Gastric and salivary secretion following injury, The systemic response to injury. Ann Surg 1955; 141:342–66.
Davenport HW. Physiology of the digestive tract. 2nd Ed. Chicago: Year Book Medical Publisers Inc., 1966(165–6).
Margieson GR, Sorby WA, Williams HBL.
The action of metoclopramide on gastric emptying. A radiological assessment. Med J Australia 1966; 2:1272–4.
James WB, Hume R.
Action of metoclopramide on gastric emptying and small bowel transit time. Gut 1968; 9:203–5.
Howarth FH, Cockel R, Roper BW, Hawkins CF.
The effect of metoclopramide upon gastric motility and its value in barium progress meals. Clinical Radiology 1969; 20:294–300.
Davies JAH, Howells TH. Management of anaesthesia for the full stomach case in the casualty department. Postgrad Med J 1973, 45, (July suppl) 58–63.
Postoperative vomiting after ether/air anaesthesia. Anaesthesia 1965; 20:199–206.
The prevention of postoperative vomiting. Br J Anaesth 1963; 35:180–8.
Peroutka SJ, Snyder SH.
Antiemetics; neuro-transmitter receptor binding predicts therapeutic actions. Lancet 1982; 1:658–9.
Adriana J, Summers FW, Anthony SO. Is the prophylactic use of antiemetics in surgical patients justified? JAMA 1961; 175:666–71.
Mirakhur RK, Dundee JW.
Lack of antiemetic effect of glycopyrrolate. Anaesthesia 1981; 36:819–20.
Antimotion sickness and antiemetic drugs. Drugs 1979; 17:471–9.
Clarke RSJ. Dundee JW, Love WJ.
Studies of drugs given before anaesthesia. VIII. Morphine 10 mg alone and with atropine or hyoscine. Br J Anaesth 1965; 37:772–7.
Laborit H, Huguenard P, Alluaume R.
Un nouveau stabilisateur vegetatif, le 4560 R P. Presse Med 1952; 60:206–8.
Paton WDM, Payne JP. Pharmacological principles and practice. London: J. and A. Churchill Ltd., 1969 (p. 117).
Knapp MR, Beecher HK. Postanesthetic nausea, vomiting and retching. JAMA 1956; 160:376–85.
Antiemetic drugs in anaesthesia. Anaesthesia 1960; 15:289–97.
Brock-Utne JG, Rubin J, Welman S, Dimopoulos GE, Moshal MG, Downing JW.
The action of commonly used antiemetics on the lower oesophageal sphincter. Br J Anaesth 1978; 50:295–88.
Loeser EA, Bennet G, Stanley TH, Machin R.
Comparison of droperidol, haloperidol and prochlor- perazine as postoperative antiemetics. Can Anaesth Soc J 1979; 26:125–7.
Dundee JW, Assaf RAE, Loan WB, Morrison JD. A comparison of the efficacy of cyclizine and per- phenazine in reducing the emetic effects of morphine and pethidine. Br J Clin Pharm 1975; 2:81–5.
Ayd J Jr.
A survey of drug induced extapyramidal reactions. JAMA 1961; 175:1054–60.
Shields GK, Ballinger CM, Hathaway BN.
Antiemetic effectiveness of haloperidol in human volunteers challenged with apomorphine. Anesth Analg 1971; 50:1017–27.
Double blind evaluation of haloperidol for antiemetic activity. Anesth Analg 1972; 51:964–7.
Goodman LS, Gilman A. The pharmacological basis of therapeutics. 5th Ed. Philadelphia: Macmillan Publishing Co. Ltd., 1975 (p. 166).
Patton CM, Moon MR, Dannemiller FJ.
The prophylactic antiemetic effect of droperidol. Anesth Analg 1974; 53:361–4.
Iwamoto K, Schwartz H.
Antiemetic effect of droperidol after ophthalmic surgery. Arch Ophthalmol 1978; 96:1378–9.
Korttila K, Kauste A, Auvinen J.
Comparison of domperidone and metoclopramide in the prevention and treatment of nausea and vomiting after balanced general anaesthesia. Anesth Analg 1979; 58:396–400.
Rita L, Goodarzi M, Seleny F.
Effect of low dose droperidol on postoperative vomiting in children. Can Anaesth Soc J 1981; 28:259–62.
Bovet D, Horclois R, Walthert F. Proprietes anti- histaminiques de la N-p-methoxybenzyl-N-dimethylaminoethyl alpha amino-pyridine. Cr Seanc Soc Biol 1944; 1938:99–100.
Bonica JJ, Crepps W, Monk B, Bennett B.
Post- anesthetic nausea retching and vomiting. Anesthesiology 1958; 19:532–40.
Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS.
Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs 1982; 24:360–400.
Pinder RM, Brogden RN, Sawyer PR, Speight TM, Avery GS.
Metoclopramide: A review of its pharmacological properties and clinical use. Drugs 1976; 12:81–131.
Shah ZP, Wilson J.
An evaluation of metoclopramide as an antiemetic in minor gynaecological surgery. Br J Anaesth 1972; 44:865–7.
Ellis FR, Spence AA.
Clinical trials of metoclopramide as an antiemetic in anaesthesia, Anaesthesia 1970;25:368–71.
Assaf RAE, Clarke RSJ, Dundee JW, Samuel IO.
Studies of drugs given before anaesthesia. XXIV: Metoclopramide with morphine and pethidine. Br J Anaesth 1974;46:514–9.
Clarke MM, Storrs JA.
The prevention of postoperative vomiting after abortion; Metoclopramide. BrJ Anaesth 1969; 41:890–2.
Clinical studies with the new antiemetic metoclopramide. Anesth Analg 1969; 48:198–204.
Handley AJ. Metoclopramide in the prevention of postoperative nausea and vomiting, Br J Clin Practice 1967; 21:460–22.
omyn DJ, Ball RW.
Prevention of postoperative nausea and vomiting by domperidone. S Afr Med J 1979; 56:827–9.
Wilson DB, Dundee JW.
Evaluation of the antiemetic action of domperidone. Anaesthesia 1979; 34:765–77.
Fragen RJ, Caldwell N.
A new benzimidazole antiemetic, domperidone, for the treatment of postoperative nausea and vomiting. Anesthesiology 1978; 49:289–90.
Zegveld C, Knape H, Smiths J et al.
Domperidone in the treatment of postoperative vomiting: A double blind multicentre study. Anesth Analg 1978; 57:700–3.
Boghaert A, Carron D, Gallant J, Stockman A. Postoperative vomiting treated with domperidone. A double blind comparison with metoclopramide and a placebo. Acta Anaesth Belgica 1980; 31:129- 37.
Fragen RJ, Caldwell N.
Antiemetic effectiveness of intramuscularly administered domperidone. Anesthesiology 1979; 51:460–1.
Intravenous lorazepam to prevent nausea and vomiting associated with cancer chemotherapy. Lancet 1981; 1:91–2.
Friedlander M, Kearsley JH, Tattersall MHN.
Oral lorazepam to improve tolerance of cytotoxic therapy. Lancet 1981; 1:1316–7.
Sallan SE, Zinberg NE, Frei E.
Antiemetic effects of delta 9 tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med 1975; 293:795–7.
Lucas VS, Laszlo J.
Delta 9 tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy. JAMA 1980; 243:1241–3.
agy C, Furnas B, Williams SD.
Nabilone: an effective antiemetic in patients receiving cancer chemotherapy. J Clin Pharmacol 1981; 21:64S-9S.
Marijuana for drug induced nausea and vomiting. JAMA 1980; 243:1265.
PubMed CrossRef Copyright information
© Canadian Anesthesiologists 1984